Neuraminidase inhibitors in pandemic A/H1N1 fluBMJ 2010; 340 doi: https://doi.org/10.1136/bmj.c130 (Published 13 January 2010) Cite this as: BMJ 2010;340:c130
- J Todd Weber, on assignment from US Centers for Disease Control and Prevention1,
- Angus Nicoll, coordinator1,
- Carolyn B Bridges, associate director for science2,
- Bruno C Ciancio, senior expert1
- 1Influenza Programme, European Centre for Disease Prevention and Control (ECDC), 171 83 Stockholm, Sweden
- 2Influenza Division, Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
Jefferson and colleagues describe the effectiveness of neuraminidase inhibitors in otherwise healthy adults infected with seasonal flu virus,1 but it is mainly the A/H1N1 flu virus that is currently in circulation.
Given the limited availability of vaccine against 2009 pandemic A/H1N1 flu, antiviral drugs have assumed a prominent role in reducing severe flu …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial